The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...

More and more, as momentum builds for the soon-to-be-blockbuster Winrevair, Merck’s $11.5 billion buyout of Acceleron in 2021 is looking like a savvy move. | Paving the way for the label update were ...

A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that ...

Diseases that primarily affect populations in low- and middle-income countries (LMICs) have a substantial toll on human health. Annually, more than one billion people are affected by a World Health ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on regenerative medicines for Huntington’s disease. The report includes a detailed analysis of the pipeline ...